Clinical Endpoint Study of Ivermectin 1% Cream

Clinical trial NCT02840461 · COMPLETED

Trial details

NCT number: NCT02840461
Sponsor: Actavis Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Moderate to Severe Papulopustular Rosacea

Start date: 2016-06-01
Primary completion: 2016-11-01
Enrollment: 630

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.